Citation Tools

Download PDFPDF

Original research
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials

Download to a citation manager

Cite this article as:
Sweet K, Song Q, Loza MJ, et al
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials